COLA II研究PPT课件.pptVIP

Is Reluctance to Prescribe Carvedilol in the Elderly Justified? The COLA II Study Utilisation of ?-Blockade for CHFin Clinical Practice BRING UP Reasons for Not Commencing β-Blockade Age of Patients in Major β-Blocker CHF Clinical Trials CASE Study Patients with Heart Failure (Total n = 22,060) Effect of β-Blocker vs Placebo on Mortality Non-Elderly Subjects Effect of β-Blocker vs Placebo on Mortality Elderly Subjects SENIORSAll Cause Mortality or CV Hospital Admission Death or CV Hospitalisation by Subgroup BRING UPIndependent Predictors of ? Blockers Tolerability COLA IIBackgroun